Eversept Partners, LP Sesen Bio, Inc. Transaction History

Eversept Partners, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$1.3 - $3.24 $2.03 Million - $5.05 Million	-1,559,824 Closed	0 $0
Q4 2020 Nov 08, 2023	BUY	$1.01 - $1.77 $1.58 Million - $2.76 Million	1,559,824 New	1,559,824 $2.11 Million
Q3 2020 Nov 08, 2023	SELL	$0.67 - $1.4 $294,917 - $616,246	-440,176 Reduced 22.01%	1,559,824 $2.18 Million
Q3 2020 Nov 13, 2020	SELL	$0.67 - $1.4 $294,917 - $616,246	-440,176 Reduced 22.01%	1,559,824 $2.18 Million
Q2 2020 Nov 08, 2023	BUY	$0.52 - $0.87 $364,000 - $609,000	700,000 Added 53.85%	2,000,000 $1.44 Million
Q2 2020 Aug 13, 2020	BUY	$0.52 - $0.87 $364,000 - $609,000	700,000 Added 53.85%	2,000,000 $1.44 Million
Q4 2019 Nov 08, 2023	BUY	$0.89 - $1.5 $1.16 Million - $1.95 Million	1,300,000 New	1,300,000 $1.35 Million
Q4 2019 Feb 13, 2020	BUY	$0.89 - $1.5 $1.16 Million - $1.95 Million	1,300,000 New	1,300,000 $1.35 Million

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.